The global implantable insulin pumps market is poised to grow on an exponential note based on the growing inclination toward adoption of intelligent system followed by personalized medicine. Implantable pump therapy performs restoration of metabolic control as well as quality of life in patients suffering from Type 1 diabetes.
The implantable insulin pumps market manufacturers are working toward adopting a device that would encompass encapsulated cells producing insulin, apart from a tiny oxygen-producing factory keeping the cells healthy.
They are also exploring the possibility of reaching out to the untapped geographies to widen their base of customers and looking forward for incorporation of sugar-powered implant that would produce insulin as per requirement.
An implantable insulin pump is referred to as a surgically implanted pump under the skin along with a catheter from pump extending into peritoneal cavity. The liver thus receives insulin in higher concentration, thereby keeping a larger percentage of it and allowing a nominal amount to pass to the rest of the body.
Users of the implanted insulin pump have reported improvement in their wellbeing. The closed-loop insulin pumps, generally called ‘artificial pancreas’, are the pumps meant to respond to readings automatically. The continuous glucose monitor needs to be worn by user every single day.
An open-loop insulin delivery system amalgamates an external insulin pump and continuous monitoring of the glucose levels through a subcutaneous sensor. The main functionality of the sensor is to communicate glucose readings to pump using radio transmitter.
However, implantable insulin pumps are costlier than their counterparts. This factor may restrain their market during the forecast period.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Implantable pumps are not categorized as isolated apparatuses anymore. They are turning out to be more compatible with cellphones, continuous glucose monitors (CGMs), and connected healthcare platforms.
One can have a comprehendible approach regarding diabetes management due to data sharing, which, in turn, powers remote monitoring through medical specialists, real-time glucose insights, and personalized insulin adjustments.
HumaPen MEMOIR was launched by Eli Lilly and Company in 2007. It was the very first digital insulin pen equipped with memory. HumaPen LUXURA HD was another product offered. It is a reusable pen for those who require insulin dosing in the half-unit increments between 0.5 and 30 units.
Novo Nordisk had introduced NovoPen Echo in 2010. It is the first insulin pen with half-unit dosing features and memory. Since then, the utilization of digital insulin pumps has increased manifold. As per the University of Alabama at Birmingham, 2.4 million diabetic patients are using CGMs.
Wider scope to use digitally integrated implantable insulin pumps is thus accelerating the implantable insulin pumps market.
The data recorded by linked pumps and continuous glucose monitors (CGMs) are opening new arenas regarding individualized therapy. The machine learning algorithms are performing the task of evaluation of the patient’s data individually, thereby getting a fair idea about swings in blood sugar.
This can help in customizing the dosage of insulin and device early warning indicators of diabetes-oriented problems.
Proactive, individualized, and preventive diabetes management has been promised by the data-driven strategy mentioned above. These patterns depict a move in the direction toward intelligent, data-driven, and minimally invasive diabetic care.
Implantable insulin pumps let patients control insulin dosages by administration of controlled quantities of insulin subcutaneously, thereby averting incidence of hyperglycemia and hypoglycemia.
Advantages of implantable insulin pumps as mentioned above are thus expanding the implantable insulin pumps market size.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest implantable insulin pumps market analysis, North America led the continuous insulin infusion devices landscape in 2023 and the status quo is expected to remain unchanged during the forecast period.
This is attributed to rise in the number of diabetic patients in the U.S. The IDF Diabetes Atlas states that 29.7 million individuals aged between 20 and 79 are living with diabetes as of 2021.
Asia Pacific’s notable implantable insulin pumps market growth is ascribed to increasing number of government initiatives propagating the usage of implantable insulin pumps.
As per the OECD library, nearly 227 million individuals are battling type 2 diabetes in this region. Growing awareness regarding the precautionary measures to be taken in this regard is thus expanding the implantable insulin pumps industry size.
The key players in the implantable insulin pumps market are deploying biocompatible materials in order to lengthen the device’s life and lower the probability of negative responses. For instance, in May 2024, Arecor collaborated with Medtronic in order to create a new kind of insulin pump that would raise the precision quotient (PQ) due to this placement.
Medtronic plc, F. Hoffmann-La Roche AG, SOOIL Developments Co. Ltd., Diamesco Co., Ltd., Apex Medical Devices, Tandem Diabetes Care, Johnson & Johnson, Insulet Corporation, Aetna Inc., and Diabeloop SACA are some of the key players covered in the implantable insulin pumps market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 3.1 Bn |
| Market Forecast (Value) in 2034 | US$ 7.8 Bn |
| Growth Rate (CAGR) | 8.3% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 3.1 Bn in 2023
It is projected to grow at a CAGR of 8.3% from 2024 to 2034
Preference for assimilation of intelligent technology and customized medicine & data-driven therapeutics
Hospitals segment accounted for the largest share in 2023
North America was the dominant region in 2023
Medtronic plc, F. Hoffmann-La Roche AG, SOOIL Developments Co. Ltd., Diamesco Co., Ltd., Apex Medical Devices, Tandem Diabetes Care, Johnson & Johnson, Insulet Corporation, Aetna Inc., and Diabeloop SACA
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Implantable Insulin Pumps Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Implantable Insulin Pumps Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Implantable Insulin Pumps Market Analysis and Forecast, by Device Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Device Type, 2020-2034
6.3.1. Closed-loop Insulin Pump
6.3.2. Open-loop Insulin Pump
6.4. Market Attractiveness Analysis, by Device Type
7. Global Implantable Insulin Pumps Market Analysis and Forecast, by Disease Indication
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Disease Indication, 2020-2034
7.3.1. Type I Diabetes
7.3.2. Type II Diabetes
7.4. Market Attractiveness Analysis, by Disease Indication
8. Global Implantable Insulin Pumps Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Homecare Settings
8.3.4. Others (Research Institutes, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Implantable Insulin Pumps Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Implantable Insulin Pumps Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Device Type, 2020-2034
10.3.1. Closed-loop Insulin Pump
10.3.2. Open-loop Insulin Pump
10.4. Market Value Forecast, by Disease Indication, 2020-2034
10.4.1. Type I Diabetes
10.4.2. Type II Diabetes
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals
10.5.2. Clinics
10.5.3. Homecare Settings
10.5.4. Others (Research Institutes, etc.)
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Device Type
10.7.2. By Disease Indication
10.7.3. By End-user
10.7.4. By Country
11. Europe Implantable Insulin Pumps Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Device Type, 2020-2034
11.3.1. Closed-loop Insulin Pump
11.3.2. Open-loop Insulin Pump
11.4. Market Value Forecast, by Disease Indication, 2020-2034
11.4.1. Type I Diabetes
11.4.2. Type II Diabetes
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Homecare Settings
11.5.4. Others (Research Institutes, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Device Type
11.7.2. By Disease Indication
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Implantable Insulin Pumps Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Device Type, 2020-2034
12.3.1. Closed-loop Insulin Pump
12.3.2. Open-loop Insulin Pump
12.4. Market Value Forecast, by Disease Indication, 2020-2034
12.4.1. Type I Diabetes
12.4.2. Type II Diabetes
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Homecare Settings
12.5.4. Others (Research Institutes, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Device Type
12.7.2. By Disease Indication
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Implantable Insulin Pumps Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Device Type, 2020-2034
13.3.1. Closed-loop Insulin Pump
13.3.2. Open-loop Insulin Pump
13.4. Market Value Forecast, by Disease Indication, 2020-2034
13.4.1. Type I Diabetes
13.4.2. Type II Diabetes
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Homecare Settings
13.5.4. Others (Research Institutes, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Device Type
13.7.2. By Disease Indication
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Implantable Insulin Pumps Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Device Type, 2020-2034
14.3.1. Closed-loop Insulin Pump
14.3.2. Open-loop Insulin Pump
14.4. Market Value Forecast, by Disease Indication, 2020-2034
14.4.1. Type I Diabetes
14.4.2. Type II Diabetes
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Homecare Settings
14.5.4. Others (Research Institutes, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Device Type
14.7.2. By Disease Indication
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Medtronic plc
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. F. Hoffmann-La Roche AG
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. SOOIL Developments Co. Ltd.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Diamesco Co., Ltd.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Apex Medical Devices
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Tandem Diabetes Care
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Johnson & Johnson
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Insulet Corporation
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Aetna Inc.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Diabeloop SACA
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Device Type, 2020-2034
Table 02: Global Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 03: Global Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 04: Global Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 05: North America Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 06: North America Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Device Type, 2020-2034
Table 07: North America Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 08: North America Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 09: Europe Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Device Type, 2020-2034
Table 11: Europe Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 12: Europe Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Device Type, 2020-2034
Table 15: Asia Pacific Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 16: Asia Pacific Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 17: Latin America Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Device Type, 2020-2034
Table 19: Latin America Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 20: Latin America Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Device Type, 2020-2034
Table 23: Middle East & Africa Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 24: Middle East & Africa Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Implantable Insulin Pumps Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Implantable Insulin Pumps Market Revenue (US$ Bn), by Device Type, 2023
Figure 03: Global Implantable Insulin Pumps Market Value Share, by Device Type, 2023
Figure 04: Global Implantable Insulin Pumps Market Revenue (US$ Bn), by Disease Indication, 2023
Figure 05: Global Implantable Insulin Pumps Market Value Share, by Disease Indication, 2023
Figure 06: Global Implantable Insulin Pumps Market Revenue (US$ Bn), by End-user, 2023
Figure 07: Global Implantable Insulin Pumps Market Value Share, by End-user, 2023
Figure 08: Global Implantable Insulin Pumps Market Value Share, by Region, 2023
Figure 09: Global Implantable Insulin Pumps Market Value (US$ Bn) Forecast, 2020-2034
Figure 10: Global Implantable Insulin Pumps Market Value Share Analysis, by Device Type, 2023 and 2034
Figure 11: Global Implantable Insulin Pumps Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Implantable Insulin Pumps Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 13: Global Implantable Insulin Pumps Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 14: Global Implantable Insulin Pumps Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global Implantable Insulin Pumps Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global Implantable Insulin Pumps Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Implantable Insulin Pumps Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Implantable Insulin Pumps Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Implantable Insulin Pumps Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Implantable Insulin Pumps Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Implantable Insulin Pumps Market Value Share Analysis, by Device Type, 2023 and 2034
Figure 22: North America Implantable Insulin Pumps Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 23: North America Implantable Insulin Pumps Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America Implantable Insulin Pumps Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Implantable Insulin Pumps Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 26: North America Implantable Insulin Pumps Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe Implantable Insulin Pumps Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Implantable Insulin Pumps Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Implantable Insulin Pumps Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Implantable Insulin Pumps Market Value Share Analysis, by Device Type, 2023 and 2034
Figure 31: Europe Implantable Insulin Pumps Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 32: Europe Implantable Insulin Pumps Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe Implantable Insulin Pumps Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Implantable Insulin Pumps Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 35: Europe Implantable Insulin Pumps Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific Implantable Insulin Pumps Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Implantable Insulin Pumps Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Implantable Insulin Pumps Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Implantable Insulin Pumps Market Value Share Analysis, by Device Type, 2023 and 2034
Figure 40: Asia Pacific Implantable Insulin Pumps Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 41: Asia Pacific Implantable Insulin Pumps Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific Implantable Insulin Pumps Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Implantable Insulin Pumps Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 44: Asia Pacific Implantable Insulin Pumps Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America Implantable Insulin Pumps Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Implantable Insulin Pumps Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Implantable Insulin Pumps Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Implantable Insulin Pumps Market Value Share Analysis, by Device Type, 2023 and 2034
Figure 49: Latin America Implantable Insulin Pumps Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 50: Latin America Implantable Insulin Pumps Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America Implantable Insulin Pumps Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Implantable Insulin Pumps Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 53: Latin America Implantable Insulin Pumps Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa Implantable Insulin Pumps Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Implantable Insulin Pumps Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Implantable Insulin Pumps Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Implantable Insulin Pumps Market Value Share Analysis, by Device Type, 2023 and 2034
Figure 58: Middle East & Africa Implantable Insulin Pumps Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 59: Middle East & Africa Implantable Insulin Pumps Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa Implantable Insulin Pumps Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Implantable Insulin Pumps Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 62: Middle East & Africa Implantable Insulin Pumps Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Implantable Insulin Pumps Market
